Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000013

Chief Medical Officer sold 417 shares at $27.59 ($11,505)

  • Chief Medical Officer acquired 417 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-02-17 Option exercise 10b5-1 +417 $15.44 $6,438 44,506 D
Rodman David Malcom Chief Medical Officer 2026-02-17 Sale 10b5-1 −417 $27.59 $11,505 44,089 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-02-17 Option exercise · Stock Option 10b5-1 −417 5,417 D
Open-market sales · 417 sh · avg $27.59 · $11,505
Loading xslF345X05/wk-form4_1771372594.xml…